Study to Evaluate the Efficacy, Safety, Tolerability and Immunogenicity of 100µg NIC002 Vaccine in Cigarette Smokers Who Are Motivated to Quit Smoking.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
This study is designed to determine the efficacy of high nicotine-specific antibody titers in smoking cessation.
Epistemonikos ID: 81cb4729a06f689f1528c46582c09ad34dd3ac8f
First added on: May 05, 2024